PharmaNutra SpA (IT:PHN)
:PHN
Total Valuation
PharmaNutra SpA has a market cap or net worth of €745.44M. The enterprise value is €755.78M.
Market Cap€745.44M
Enterprise Value€755.78M
Share Statistics
PharmaNutra SpA has 9,680,977 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,680,977
Owned by Insiders34.54%
Owned by Institutions―
Financial Efficiency
PharmaNutra SpA’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 20.15%.
Return on Equity (ROE)0.28
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)20.15%
Return on Capital Employed (ROCE)0.32
Revenue Per Employee1.12M
Profits Per Employee169.51K
Employee Count118
Asset Turnover1.05
Inventory Turnover11.52
Valuation Ratios
The current PE Ratio of PharmaNutra SpA is 26.0. PharmaNutra SpA’s PEG ratio is 1.25.
PE Ratio26.0
PS Ratio3.95
PB Ratio7.28
Price to Fair Value7.28
Price to FCF31.63
Price to Operating Cash Flow38.26
PEG Ratio1.25
Income Statement
In the last 12 months, PharmaNutra SpA had revenue of 131.69M and earned 20.00M in profits. Earnings per share was 2.09.
Revenue131.69M
Gross Profit29.71M
Operating Income30.31M
Pretax Income30.19M
Net Income20.00M
EBITDA34.21M
Earnings Per Share (EPS)2.09
Cash Flow
In the last 12 months, operating cash flow was 19.56M and capital expenditures -3.12M, giving a free cash flow of 16.44M billion.
Operating Cash Flow19.56M
Free Cash Flow16.44M
Free Cash Flow per Share1.70
Dividends & Yields
PharmaNutra SpA pays an annual dividend of €1, resulting in a dividend yield of 1.86%
Dividend Per Share€1
Dividend Yield1.86%
Payout Ratio55.56%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.38
52-Week Price Change63.55%
50-Day Moving Average68.28
200-Day Moving Average54.03
Relative Strength Index (RSI)64.44
Average Volume (3m)25.97K
Important Dates
PharmaNutra SpA upcoming earnings date is May 11, 2026, TBA (Confirmed).
Last Earnings DateMar 17, 2026
Next Earnings DateMay 11, 2026
Ex-Dividend Date―
Financial Position
PharmaNutra SpA as a current ratio of 2.35, with Debt / Equity ratio of 28.75%
Current Ratio2.35
Quick Ratio2.06
Debt to Market Cap0.04
Net Debt to EBITDA0.06
Interest Coverage Ratio27.86
Taxes
In the past 12 months, PharmaNutra SpA has paid 10.27M in taxes.
Income Tax10.27M
Effective Tax Rate0.34
Enterprise Valuation
PharmaNutra SpA EV to EBITDA ratio is 15.25, with an EV/FCF ratio of 31.75.
EV to Sales3.96
EV to EBITDA15.25
EV to Free Cash Flow31.75
EV to Operating Cash Flow26.66
Balance Sheet
PharmaNutra SpA has €30.61M in cash and marketable securities with €20.51M in debt, giving a net cash position of €10.10M billion.
Cash & Marketable Securities€30.61M
Total Debt€20.51M
Net Cash€10.10M
Net Cash Per Share€1.04
Tangible Book Value Per Share€4.89
Margins
Gross margin is 30.75%, with operating margin of 23.02%, and net profit margin of 15.19%.
Gross Margin30.75%
Operating Margin23.02%
Pretax Margin22.92%
Net Profit Margin15.19%
EBITDA Margin25.98%
EBIT Margin23.02%
Analyst Forecast
The average price target for PharmaNutra SpA is €82.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€82.67
Price Target Upside7.36% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast12.82%
EPS Growth Forecast7.37%